Chronic pain is commonly defined as any pain which lasts more than 12 weeks. Common causes of chronic back pain include: According to research, 50 percent of the adult population will report headaches during the. Common chronic pain complaints include headache, low back pain, cancer pain, arthritis A recent market research report indicates that more than billion people When asked about four common types of pain, respondents of a National. Chronic pain is pain that lasts a long time. In medicine, the distinction between acute and Psychological treatments including cognitive behavioral therapy and Visceral pain may be well-localized, but often it is extremely difficult to locate, and Complete and sustained remission of many types of chronic pain is rare.
MOST OF PAIN TYPES COMMONLY REPORTED THE INCLUDE: CHRONIC
Such a fear might limit a person's ability to return to their regular work or leisure activities. Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services.
Chronic Pain Acute pain can be mild and last just a moment, or it might be severe and last for weeks or months. What is the difference between acute and chronic pain? Causes of acute pain include: Surgery Broken bones Dental work Burns or cuts Labor and childbirth After acute pain goes away, a person can go on with life as usual. Chronic pain is pain that lasts a long time. In medicine, the distinction between acute and chronic pain is sometimes determined by an arbitrary interval of time since onset; the two most commonly used markers being 3 months and 6 months since onset,  though some theorists and researchers have placed the transition from acute to chronic pain at 12 months.
Chronic pain may originate in the body, or in the brain or spinal cord. It is often difficult to treat. Various nonopioid medicines are recommended initially, depending on whether the pain originates from tissue damage or is neuropathic.
Some people with chronic pain may benefit from opioid treatment while others are harmed. Severe chronic pain is associated with increased 10 year mortality, particularly from heart disease and respiratory disease. People with chronic pain tend to have higher rates of depression, anxiety, and sleep disturbances; these are correlations and it is often not clear which factor causes another.
Chronic pain may contribute to decreased physical activity due to fear of exacerbating pain, often resulting in weight gain. Pain intensity, pain control, and resiliency to pain are influenced by different levels and types of social support that a person with chronic pain receives.
The International Association for the study of pain defines chronic pain as pain with no biological value, that persists past normal tissue healing. The DSM-5 recognizes one chronic pain disorder, somatic symptom disorders, a reduction from the three previously recognized pain disorders. The criteria include it lasting for greater than six months. The suggested ICD chronic pain classification suggests 7 categories for chronic pain.
Chronic pain may be divided into " nociceptive " caused by inflamed or damaged tissue activating specialised pain sensors called nociceptors , and " neuropathic " caused by damage to or malfunction of the nervous system. Nociceptive pain may be divided into "superficial" and "deep", and deep pain into "deep somatic " and " visceral ".
Superficial pain is initiated by activation of nociceptors in the skin or superficial tissues. Deep somatic pain is initiated by stimulation of nociceptors in ligaments, tendons, bones, blood vessels, fasciae and muscles, and is dull, aching, poorly-localized pain. Visceral pain originates in the viscera organs.
Visceral pain may be well-localized, but often it is extremely difficult to locate, and several visceral regions produce "referred" pain when damaged or inflamed, where the sensation is located in an area distant from the site of pathology or injury. Neuropathic pain  is divided into "peripheral" originating in the peripheral nervous system and " central " originating in the brain or spinal cord. Under persistent activation nociceptive transmission to the dorsal horn may induce a pain wind-up phenomenon.
This induces pathological changes that lower the threshold for pain signals to be transmitted. In addition it may generate nonnociceptive nerve fibers to respond to pain signals. Nonnociceptive nerve fibers may also be able to generate and transmit pain signals. The type of nerve fibers that are believed to propagate the pain signals are the C-fibers, since they have a slow conductivity and give rise to a painful sensation that persists over a long time.
Chronic pain of different etiologies has been characterized as a disease affecting brain structure and function. Magnetic resonance imaging studies have shown abnormal anatomical  and functional connectivity, even during rest   involving areas related to the processing of pain.
Also, persistent pain has been shown to cause grey matter loss, reversible once the pain has resolved. These structural changes can be explained by the phenomenon known as neuroplasticity. In the case of chronic pain, the somatotopic representation of the body is inappropriately reorganized following peripheral and central sensitization. This maladaptive change results in the experience of allodynia or hyperalgesia.
Brain activity in individuals with chronic pain, measured via electroencephalogram EEG , has been demonstrated to be altered, suggesting pain-induced neuroplastic changes.
More specifically, the relative beta activity compared to the rest of the brain is increased, the relative alpha activity is decreased, and the theta activity both absolutely and relatively is diminished.
Dopaminergic dysfunction has been hypothesized to act as a shared mechanism between chronic pain, insomnia and major depressive disorder. Increased tonic dopamine activity and a compensatory decrease in phasic dopamine activity, which is important in inhibiting pain.
This is supported by the implication of COMT in fibromyalgia and temporomandibular joint syndrome. Increased activity of microglia, alterations of microglial networks as well as increased production of chemokines and cytokines by microglia are proposed to act to potentiate pain. Astrocytes have been observed to lose their ability to regulate the excitability of neurons, increasing spontaneous neural activity in pain circuits. Pain management is the branch of medicine employing an interdisciplinary approach to the relief of pain and improvement in the quality of life of those living with pain.
Initially recommended efforts are non opioid based therapies. Various nonopioid medicines are used, depending on whether the pain originates from tissue damage or is neuropathic. Limited evidence suggests that chronic pain from tissue inflammation or damage as in rheumatoid arthritis and cancer pain is best treated with opioids, while for neuropathic pain pain caused by a damaged or dysfunctional nervous system other drugs may be more effective,     such as tricyclic antidepressants ,  serotonin-norepinephrine reuptake inhibitors ,  and anticonvulsants.
Withholding, interrupting or withdrawing opioid treatment in people who benefit from it can cause harm. Interventional pain management may be appropriate, including techniques such as trigger point injections , neurolytic blocks , and radiotherapy. While there is no high quality evidence to support ultrasound , it has been found to have a small effect on improving function in non-specific chronic low back pain. Psychological treatments, including cognitive behavioral therapy   and acceptance and commitment therapy   have been shown effective for improving quality of life and reducing pain interference in those with chronic pain.
Well-described apparent musculoskeletal conditions for which the causes are incompletely understood, such as nonspecific back pain or chronic widespread pain, will be included in the section on chronic primary pain. Irrespective of its etiology, chronic pain is a major source of suffering and requires special treatment and care. Our proposal may not represent a perfect solution for the classification of all manifestations of chronic pain.
However, it does represent the first systematic approach to implementing a classification of chronic pain in the ICD. It is based on international expertise and agreement, and consistent with the requirements of the ICD regarding the structure and format of content models.
The 7 major categories of chronic pain were identified after considerable research and discussion. They represent a compromise between comprehensiveness and practical applicability of the classification system. Several clinically important conditions that were neglected in former ICD revisions will now be mentioned, eg, chronic cancer pain or chronic neuropathic pain.
Etiological factors, pain intensity, and disability related to pain will be reflected. With the introduction of chronic primary pain as a new diagnostic entity, the classification recognizes conditions that affect a broad group of patients with pain and would be neglected in etiologically defined categories.
We hope that this classification strengthens the representation of chronic pain conditions in clinical practice and research and welcome comments to improve it further. Aziz has attended advisory board meetings for Almirall pharmaceuticals and Grunenthal.
He has also received funding for clinical trials from Ono Pharmaceutical and Protexin. Bennett has received consultancy or speaker fees from Pfizer, Bayer, Astellas, and Grunenthal in the last 5 years. Cohen has received honoraria for contributions to educational programs from Mundipharma Pty Limited and Pfizer.
First on the faculty of the Lundbeck International Neuroscience Foundation. In the past 2 years, M. Giamberardino received research funding or honoraria participation in Advisory Board from Bayer Healthcare, Helsinn, and Epitech Group. Kaasa declares no conflict of interest related to this work.
In the past year he received honoraria from Helsinn related to participation in Advisory Board. Kosek has received consultancy and speaker fees in the past 24 months from Eli Lilly and Company and Orion and has ongoing research collaborations with Eli Lilly and Company and Abbott and Pierre Fabre. Nicholas received honoraria for contributing to educational sessions for Mundipharma and Pfizer in the last 5 years.
He has received grant support from BMS. He has received grant support from GlaxoSmithKline and Pfizer. Smith has received lecture and consultancy fees, on behalf of his institution, from Pfizer, Grunenthal, Eli Lilly, and Napp. He has received unconditional educational grants from Pfizer Ltd; and he has received travel and accommodation support from Napp. Svensson served as a paid consultant for Sunstar Suisse SA. Wang has served on the advisory boards of Allergan and Eli Lilly, Taiwan.
The other authors have no conflicts of interest to declare. Barke contributed equally to this topical review. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. National Center for Biotechnology Information , U. Published online Mar Finnerup , h Michael B. Smith , r Peter Svensson , s, t Johan W. Vlaeyen , u, v and Shuu-Jiun Wang w.
Author information Article notes Copyright and License information Disclaimer. The work cannot be changed in any way or used commercially. This article has been cited by other articles in PMC.
Introduction Chronic pain has been recognized as pain that persists past normal healing time 5 and hence lacks the acute warning function of physiological nociception. Table 1 Glossary of ICD terms. Open in a separate window. Classification of chronic pain Chronic pain was defined as persistent or recurrent pain lasting longer than 3 months.
Chronic primary pain Chronic primary pain is pain in 1 or more anatomic regions that persists or recurs for longer than 3 months and is associated with significant emotional distress or significant functional disability interference with activities of daily life and participation in social roles and that cannot be better explained by another chronic pain condition.
Chronic cancer pain Pain is a frequent and debilitating accompaniment of cancer 8 that as yet has not been represented in the ICD. Chronic postsurgical and posttraumatic pain Because pain that persists beyond normal healing is frequent after surgery and some types of injuries, the entity of postsurgical and posttraumatic pain was created.
Chronic neuropathic pain Chronic neuropathic pain is caused by a lesion or disease of the somatosensory nervous system. Chronic headache and orofacial pain The International Headache Society IHS has created a headache classification 17 that is implemented in full in the chapter on neurology. Chronic visceral pain Chronic visceral pain is persistent or recurrent pain that originates from the internal organs of the head and neck region and the thoracic, abdominal, and pelvic cavities.
Chronic musculoskeletal pain Chronic musculoskeletal pain is defined as persistent or recurrent pain that arises as part of a disease process directly affecting bone s , joint s , muscle s , or related soft tissue s. Outlook Irrespective of its etiology, chronic pain is a major source of suffering and requires special treatment and care.
Conflict of interest statement Q.
Chronic pain is the number one cause of long-term disability in the United States. 4) The most likely people to report pain lasting more than 24 hours are adults aged 2) The four most common types of chronic pain are. Other cases have no apparent cause -- no prior injury and an And among people with chronic pain stemming from a work-related injury, those who report poor job "Depression is common in chronic pain patients, but people who Low-impact forms of exercise like walking, bicycling, swimming, and. Chronic pain is pain that is ongoing and usually lasts longer than six months. It goes away when there is no longer an underlying cause for the pain. This type of pain can continue even after the injury or illness that caused it has healed or.